Announcement

Collapse
No announcement yet.

President Serzh Sargsyan visits Liqvor pharmaceutical company

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • President Serzh Sargsyan visits Liqvor pharmaceutical company

    President Serzh Sargsyan visits Liqvor pharmaceutical company

    http://www.nt.am/news.php?shownews=101282 7

    YEREVAN, MARCH 10, NOYAN TAPAN. Armenian president Serzh Sargsyan
    visited Liqvor CJSC on March 7. According to the director general of
    the company Sergei Matevosian, the visit of the president was related
    to March 8 as most of Liqvor's employees are women, while the other
    purpose of the visit was to become acquainted with the company's
    activities.

    S. Matevosian said that Liqvor was founded in 1991. It mainly produces
    intravenous solutions and ophthalmological drugs (60 types of drugs of
    26 pharmaceutical groups), and their production is sold both in Armenia
    and almost all CIS countries. About 40% of production is exported. The
    company has 83 main employees, while their total number makes 107.

    It was mentioned that the global economic crisis has had its impact on
    Liqvor, mainly in respect of foreign markets, whereas sales in the
    domestic market have not declined.

    In the words of S. Matevosian, the company has submitted a business
    plan to the RA government's anticrisis operative staff with an
    expectation of support, and the business plan is now being discussed.
    The RA minister of economy Nerses Yeritsian said that Liqvor exports
    medicines of a million dollars a year, which is quite a high index for
    a pharmaceutical company. The business plan of the company is related
    to construction of a new factory, which will enable to create jobs in
    construction sector and to establish a high-tech production, which will
    provide Liqvor with an opportunity to increase its exports.

    The indicated business plan envisages a 10-year period, and after its
    implementation the value of the company will grow several fold.
    Besides, it is envisaged introducing GMP standards at Liqvor and
    increasing the range of its production based on own scientific
    developments. According to the minister, in recent years the company's
    revenues grew by 30-50% annually, and Liqvor can build a new factory
    with its own resources, but state assistance would allow it to reduce
    the period of construction work. He noted that one guarantee of success
    of Liqvor's plans is 40% participation of the EBRD in the company's
    capital (August 2005).

    Liqvor has submitted a business plan on receiving a 2.4 million dollar
    credit to the government. Out of this sum, 1.8 million dollars will be
    spent on construction of a new factory in Jrvezh district of Yerevan's
    Nor Nork community. The amount of envisaged investments makes 3m 480
    thousand dollars.
Working...
X